|Day Low/High||30.14 / 31.33|
|52 Wk Low/High||37.59 / 67.34|
Strong quarterly performances from Target Corp. and Urban Outfitters Inc. inspired broader retail gains.
Target and Urban Outfitters sweetened investor appetite for retail names.
Mylan execs have criticized the FDA, which they say has been too slow to approve competitors to complex drugs.
The companies are subject to either state, federal or congressional inquiries into their marketing practices for prescription opioids, which are blamed for helping to fuel rising numbers or addicted individuals.
The most recent short interest data has been released for the 07/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
All three major U.S. indexes declined.
Mylan might be trapping the bears here in a big way.
North America segment third-party net sales were $1.28B during the second quarter.
Wall Street pulled lower mid-week on worries over rising tensions between the U.S. and North Korea.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Wednesday's trending stocks.
Geopolitical risk is heating up and investors are feeling it.
U.S. stock futures fall amid increasingly dangerous rhetoric between North Korea and the United States.
Mylan is first to offer innovative, reduced-dose HIV treatment in India
DJIA, S&P 500 and Nasdaq all rise slightly on the session.
RBC Capital analyst Randall Stanicky thinks Mylan is not immune to the broader challenges facing the generic drug industry.
The Dow has closed with a record for eight straight days. It's going for its ninth.
The Dow could close with its ninth day of records.
Horizon Pharma, Mylan and Intellia Therapeutics were among the biotech stock movers in premarket trading on Aug. 7.
Mylan's TLD is the first fixed-dose combination of its kind to be offered to patients being treated for HIV/AIDS
I would look to begin trading it on the long side above $160.